Navigation Links
Cedars-Sinai immunotherapy expert honored for work in kidney transplantation
Date:8/7/2014

LOS ANGELES (Aug. 8, 2014) Ashley Anh Vo, PharmD, administrative director of the Transplant Immunotherapy Program at the Comprehensive Transplant Center at Cedars-Sinai, has been named the 2014 Clinician of Distinction by the American Society of Transplantation for her work in developing anti-rejection drug protocols for patients.

"This prestigious award recognizes Dr.Vo's clinical excellence and the creative scholarship she brings to the field of transplantation," said Andrew S. Klein MD, FACS, MBA, director of the Cedars-Sinai Comprehensive Transplant Center. "This is a unique achievement that represents her dedication and tireless work on behalf of transplant patients."

Vo received the award at the recent World Transplant Congress in San Francisco, where Cedars-Sinai kidney transplant clinicians and researchers contributed nearly 30 abstracts and presentations to the international gathering. One of the most highly anticipated presentations involved preliminary research of a new anti-rejection drug known as C1-INH by Stanley C. Jordan, MD, director of kidney transplantation and transplant immunology at Cedars Sinai. Patients in the small trial who received C1-INH after transplantation developed fewer complications.

Vo's research in immunotherapy began in 1994 when she became the transplant pharmacist for Cedars-Sinai and joined a National Institutes of Health investigation headed by Jordan. Since then, Vo and Jordan have collaborated extensively, producing the 2004 landmark study that identified new anti-rejection treatments.

That study tested IVIG, intravenous immunoglobulin, as an effective therapy for lowering a patient's level of HLA antibodies, which can cause a patient's body to reject a transplanted organ. Patients who have been pregnant, been on kidney dialysis or received many blood transfusions often develop HLA antibodies, making it very hard for them to have a successful kidney transplant.

"Dr. Vo has played a key role in our research identifying how IVIG treatment significantly reduces the long amount of time a patient can remain on dialysis, suffering, waiting for a suitable transplant because their HLA antibody levels put them at a high risk of organ rejection," said Jordan. "Her work has been an important asset to the entire field of organ transplantation."


'/>"/>

Contact: Laura Coverson
laura.coverson@cshs.org
310-423-5215
Cedars-Sinai Medical Center
Source:Eurekalert

Related medicine news :

1. California Healthcare Institute Adds Executives from Gilead Sciences, Cedars-Sinai and Versant Ventures to Its Board
2. Cedars-Sinai study identifies heart-specific protein that protects against arrhythmia
3. Cedars-Sinai surgeon and policymaker honored for work in liver disease and transplantation
4. Grant supports Cedars-Sinai study of possible links between air pollution and brain cancer
5. Cedars-Sinai clinical trial studies vaccine targeting cancer stem cells in brain cancers
6. Update: 50 percent of patients in Cedars-Sinai brain cancer study alive after 5 years
7. Prominent Cedars-Sinai medical physicist receives highest honor from distinguished association
8. Cedars-Sinai opens first-of-its-kind trial in western US for metastatic carcinoid cancer patients
9. Heart valve repair innovator receives Cedars-Sinai Heart Institutes Corday Prize in Heart Research
10. Cedars-Sinai study: Obesity may be linked to microorganisms living in the gut
11. Nobel laureate Roger Tsien, Ph.D., keynotes Cedars-Sinai nanomedicine conference March 15, 16
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... ... , ... February is American Heart Month sponsored by The American Heart Association. ... cardiovascular health for themselves, their families and their communities. , Heart disease is ... deaths are caused by heart disease. Nearly half of all Americans have at least ...
(Date:2/28/2017)... ... February 28, 2017 , ... Roxanna Cross will ... at the 11th Annual RISE Nashville Summit. RISE Nashville is the healthcare industry’s ... engagement strategies. , The discussion will include best practices for accurate identification and ...
(Date:2/27/2017)... ... February 27, 2017 , ... Robert E. Burke, MD, PhD, had a successful ... upbringing and life experiences could have led him down a much different path. , ... of Parenting, Perseverance and Pediatrics,” Dr. Burke shares a personal account of the tribulations ...
(Date:2/27/2017)... ... 27, 2017 , ... Elisa Guajardo Carothers is not your typical author. She went from working ... nun. Now, she writes about God, when she isn’t swimming as a performing mermaid. , ... is BS! (Before Satan),” she offers a comedic look at the dysfunctions of God’s family, ...
(Date:2/27/2017)... ... February 27, 2017 , ... POUGHKEEPSIE, N. Y. – Peer-reviewed guidelines from ... scientific studies, the Center for Disease Control ( CDC ) and Infectious Diseases Society ... B. Liegner, M.D. has compiled into a single volume a compelling argument that the ...
Breaking Medicine News(10 mins):
(Date:2/28/2017)... 27, 2017 Pulmonary drug delivery market is ... USD 36.10 billion in 2016, at a CAGR of ... route as an alternate route of drug delivery, rising ... incidence of respiratory diseases such as COPD, asthma, and ... during the forecast period. However, emerging markets and growth ...
(Date:2/28/2017)... -- Medical robots market is projected to reach USD ... 2016, growing at a CAGR of 21.1% in the ... Read the full report: http://www.reportlinker.com/p04730562-summary/view-report.html ... advancements, increase in funding for medical robots research, issuance ... investments are the key factors driving the growth of ...
(Date:2/28/2017)... global  pulse oximeters market  is expected to reach USD 2.8 billion by 2025, ... market is anticipated to witness significant growth during the forecast period, which can ... pulmonary disease (COPD), sleep apnea, cardiac arrhythmia, and ischemic conditions. ... ... View Research Logo ...
Breaking Medicine Technology: